Abstract
The carbonyl assay has been developed as a general assay of oxidative protein damage to assess steady-state protein damage in animal tissues and body fluids. The assay is based on the fact that several ROS can attack amino acid residues in proteins (particularly histidine, arginine, lysine, and proline) to produce carbonyl functions that can react with 2,4-dinitrophenylhydrazine (DNPH) to generate chromophoric dinitrophenylhydrazones. This reaction can, therefore, be used to estimate the carbonyl content of proteins in human tissues and body fluids. Western blotting assays based on the use of anti-dinitrophenol antibodies have also been developed to identify oxidatively damaged proteins in tissues and body fluids after their extraction and derivatization with DNPH. The carbonyl assay has become widely used and many laboratories have developed individual protocols for it. Sometimes, the assay procedures used are not precisely specified, and when they are, they may differ from those originally proposed by the group of Stadtman et al. This point is important, because there is considerable variation in the baseline levels of protein carbonyls in certain tissues, depending on how the assay is performed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
